| http://www.w3.org/ns/prov#value | - The authors also stated that there is a need for a clinical trial, with long-term follow-up, to evaluate the safety of omission of an axillary lymph node dissection in patients with a negative sentinel node after neoadjuvant chemotherapy.FundingNot stated.Bibliographic detailsvan Deurzen CH, Vriens BE, Tjan-Heijnen VC, van der Wall E, Albregts M, van Hilligersberg R, Monninkhof EM, van Diest PJ. A
|
